Ovid Therapeutics Inc (OVID) Live Share Price, Invest From India

Ovid Therapeutics Inc Stock Performance

as on January 1, 2026 at 2:29 am IST

Day's Low
Day's High
$1.59
Day's Price Range
$1.66
$1.62
1.85%
Downside
2.47%
Upside
52 Week's Low
52 Week's High
$0.24
52-Week Price Range
$2.01
$1.62
85.03%
Downside
24.07%
Upside

Ovid Therapeutics Inc share price movements today

Previous Close: $1.63
Open: $1.62
Volume: 1.4M
Day's Low - High: $1.59 - $1.66
52 Week Low - High: $0.24 - $2.01

Ovid Therapeutics Inc Historical Returns

1 Month Return: -9.44 %
3 Month Return: + 18.98 %
1 Year Return: + 74.57 %
3 Year Return: -12.37 %
5 Year Return: -29.44 %

Ovid Therapeutics Inc Stock Fundamentals & Key Indicators

Check Ovid Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$116.1M

EPS (TTM)

-0.4525

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.86

Industry PE ratio

PEG Ratio

EBITDA

-38.7M

Revenue (TTM)

6.6M

Profit Margin

0.00%

Return On Equity TTM

-60.06%

Ovid Therapeutics Inc Stock Valuation

Track how Ovid Therapeutics Inc P/E has moved over time to understand its valuation trends.

Ovid Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (-6.47x)

June 30, 2024

Industry (0.00x)

January 1, 2026

Today (-2.86x)

January 1, 2026

Highest (2.35x)

June 30, 2021

LowHigh

Today’s Price to Earnings Ratio: -2.86x

Ovid Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ovid Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Ovid Therapeutics Inc	BUY	$116.1M	-29.44%	-2.86	0.00%
Insmed Incorporated	BUY	$37.1B	422.8%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$52.5B	205.96%	1241.41	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$116.3B	91.83%	31.95	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$82.0B	59.77%	18.55	32.13%

Stock Returns calculator for Ovid Therapeutics Inc Stock including INR - Dollar returns

The Ovid Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Ovid Therapeutics Inc investment value today

Current value as on today

₹1,79,229

Returns

₹79,229

(+79.23%)

Returns from Ovid Therapeutics Inc Stock

₹74,194 (+74.19%)

Dollar Returns*

₹5,035 (+5.04%)

Analyst Recommendation on Ovid Therapeutics Inc Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Ovid Therapeutics Inc. Average target price of $4.05

Ovid Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Ovid Therapeutics Inc.

What analysts predicted

60%UPSIDE

Target Price

$4.05

Current Price

$1.62

Analyzed by

16 Analysts

Target

$4.05

Ovid Therapeutics Inc target price $4.05, a slight upside of 60% compared to current price of $1.62. According to 16 analysts rating.

Ovid Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Ovid Therapeutics Inc Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Time period: December 3, 2025 to January 2, 2026

Change:-38% versus previous 30 day period

Ovid Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	0	0	0	0	0	0	0	0	6	0
Gross Profit	0	0	0	0	0	0	0	0	6	0
Operating Income	-14	-12	-18	-17	-20	-13	-10	-12	-5	-12
EBITDA	-13	-11	-16	-17	-20	-13	-10	-12	-4	-12
Interest Expense	-	-	1,536	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-12	-11	-15	-11	8	-14	-9	-10	-4	-12
Income Tax Expense	0	0	0	0	-	-	-	-	-	-
Net Income	-12	-11	-15	-11	8	-14	-9	-10	-4	-12
Net Profit Margin	-16544.00%	-10323.85%	-10790.14%	-7901.35%	5042.01%	-8095.95%	-12175.00%	-7873.08%	-74.68%	-9210.61%

Ovid Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	12	208	1	0	0
Gross Profit	0	0	0	0	0	12	208	1	0	0
Operating Income	-13	-22	-65	-52	-61	-81	124	-55	-59	-61
EBITDA	-13	-22	-64	-52	-61	-81	124	-54	-57	-57
Interest Expense	-	-	-	-	-	-	0	2	-	-
Depreciation	-	-	0	0	0	0	0	1	1	0
Income Before Tax	-13	-22	-64	-51	-60	-81	124	-54	-52	-26
Income Tax Expense	-	0	0	0	-1	0	1	-2	0	-
Net Income	-13	-22	-64	-51	-59	-80	122	-51	-52	-26
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-639.83%	58.95%	-3420.95%	-13351.79%	-4670.14%

Ovid Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-11	-15	-11	8	-14	-9	-10	-4	-12
Operating Cash Flow	-10	-11	-16	-14	-15	-10	-10	-4	-12
Investing Cash Flow	-4	-48	20	12	0	21	5	12	5
Financing Cash Flow	0	30	0	0	0	-	0	-	0
Change in Cash	-14	-30	3	-1	-14	11	-5	7	-7

Ovid Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-22	-64	-51	-60	-81	119	-54	-52	-26
Operating Cash Flow	-17	-31	-45	-51	-51	118	-55	-45	-55
Investing Cash Flow	0	0	-5	-30	34	-1	-87	-2	54
Financing Cash Flow	0	66	0	86	47	0	0	30	0
Change in Cash	-18	35	-50	5	30	115	-142	-17	0

Global Institutional Holdings in Ovid Therapeutics Inc

Funds	Holdings
Takeda Pharmaceutical Co Ltd	10.59%
Bvf Inc	5.42%
Vanguard Group Inc	3.71%
Sio Capital Management, LLC	3.14%
Renaissance Technologies Corp	2.95%

See all

Insights on Ovid Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, OVID stock has moved up by 393.2%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 771.1% return, outperforming this stock by 783.5%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 148.8% return, outperforming this stock by 78.7%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 6.27M → 132.0K (in $), with an average decrease of 97.9% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -4.68M → -12.15M (in $), with an average decrease of 159.6% per quarter

About Ovid Therapeutics Inc

ovid therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. ovid’s drug candidate, ov101, is currently in development for the treatment of symptoms of angelman syndrome and fragile x syndrome. ovid is also developing ov935 in collaboration with takeda pharmaceutical company limited for the treatment of rare epileptic encephalopathies. ovid has initiated the phase 2 stars trial of ov101 in adults with angelman syndrome and a phase 1 trial in adolescents with angelman and fragile x syndrome to identify doses suitable for younger patients. review our community guidelines: http://www.ovidrx.com/community-guidelines/

Organisation	Ovid Therapeutics Inc
Headquarters	441 Ninth Avenue, New York, NY, United States, 10001
Industry	Health Technology
CEO	Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.
E-voting on shares	Click here to vote

Key Management of Ovid Therapeutics Inc

Name	Title
Dr. Toshiya Nishi D.V.M.	Head of Epilepsy Research
Dr. Petra Kaufmann M.D., M.S.	Chief Medical Officer
Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.	CEO & Chairman
Ms. Margaret Alexander	President & COO
Dr. Julia Tsai Ph.D.	Senior Vice President of Clinical Development
Dr. Manal Morsy M.B.A., M.D., PH.D.	Chief Regulatory Officer
Ms. Victoria Fort	Senior Vice President of Corporate Affairs & Corporate Strategy
Mr. Charles Ross Carter	Senior VP of Finance & Financial Planning
Mr. Jeffrey A. Rona	Chief Business & Financial Officer and Corporate Secretary
Dr. Zhong Zhong Ph.D.	Chief Scientific Officer

FAQs

What is Ovid Therapeutics Inc share price today?

Ovid Therapeutics Inc share price today is $1.62 as on January 1, 2026 at 2:29 am IST at the close of the market. Ovid Therapeutics Inc share today touched a day high of $1.66 and a low of $1.59.

What is the 52 week high and 52 week low for Ovid Therapeutics Inc share?

Ovid Therapeutics Inc share touched a 52 week high of $2.01 on October 3, 2025 and a 52 week low of $0.24 on April 9, 2025. Ovid Therapeutics Inc stock price today i.e. January 1, 2026 at 2:29 am IST is closed at $1.62,which is 19.40% down from its 52 week high and 568.04% up from its 52 week low.

What is Ovid Therapeutics Inc's market capitalisation today?

Ovid Therapeutics Inc market capitalisation is $0.00T as on January 1, 2026 at 2:29 am IST.

How to invest in Ovid Therapeutics Inc Stock (OVID) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ovid Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ovid Therapeutics Inc Shares that will get you 0.9259 shares as per Ovid Therapeutics Inc share price of $1.62 per share as on January 1, 2026 at 2:29 am IST.

What is the minimum amount required to buy Ovid Therapeutics Inc Stock (OVID) from India?

Indian investors can start investing in Ovid Therapeutics Inc (OVID) shares with as little as ₹89.9625 or $1 (as of January 2, 2026 at 8:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹899.63 in Ovid Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on January 2, 2026 at 8:41 am IST). Based on Ovid Therapeutics Inc share’s latest price of $1.62 as on January 1, 2026 at 2:29 am IST, you will get 6.1728 shares of Ovid Therapeutics Inc. Learn more about fractional shares .

What are the returns that Ovid Therapeutics Inc has given to Indian investors in the last 5 years?

Ovid Therapeutics Inc stock has given -29.44% share price returns and 22.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?